new dosing regimens for certain bisphosphonates, such as Actonel and Aclasta

View the FDA's preliminary statement concerning bisphosphonates and atrial fibrillation

You'll hear about new dosing regimens for certain bisphosphonates, such as Actonel and Aclasta.

It's a competitive market. There is a huge number of potential patients...and big money is at stake.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote